Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

48.09 USD -1.75 (-3.51%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Agios Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 30, 2021
Upgrades According to Craig-Hallum, the prior rating for Gentherm Inc (NASDAQ:THRM) was changed from Hold to Buy. For ... 
Tags PYPD AGIO SPSC
From Benzinga
We Did The Math FBT Can Go To $206
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Agios Pharmaceuticals, inc (AGIO) Q2 2021 Earnings Call Transcript
AGIO earnings call for the period ending June 30, 2021. 
Tags AGIO Market News
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FUSN SOPH RHHBY
From Benzinga
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
From GlobeNewswire News Releases
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism ... 
Tags Penny Stocks ALEC ALKS
From Benzinga
Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021
From GlobeNewswire News Releases
Agios Pharmaceuticals Sees RS Rating Improve To 72
Agios Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE:THO) from Neutral to Buy. For the third quarter, Thor ... 
Tags MITO BZI/Ratings Analyst Ratings
From Benzinga
Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
From GlobeNewswire News Releases
Add Up The Pieces: FXH Could Be Worth $129
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ISRG SPRB AXNX
From Benzinga
Agios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency
From GlobeNewswire News Releases
Notable Monday Option Activity: AGIO, MRNA, AZO
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Agios Pharmaceuticals Inc (AGIO), where a total of 3,348 contracts have traded so far,... 
Tags Stocks
From Market News Video
Agios Pharma Files US Application For Mitapivat In PK Deficiency
Agios Pharmaceuticals Inc(NASDAQ: AGIO) hassubmitted an FDA marketing applicationseeking approval for mitapivat to ... 
Tags Biotech FDA Market News
From Benzinga
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 49 companies set new 52-week highs. Intriguing Points: The largest company ... 
Tags 52/Week Highs NOA STXS
From Benzinga
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
From GlobeNewswire News Releases
Stocks With Rising Relative Price Strength: Agios Pharmaceuticals
Agios Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84. 
From Investor's Business Daily
First Week of July 16th Options Trading For Agios Pharmaceuticals (AGIO)
Investors in Agios Pharmaceuticals Inc (AGIO) saw new options become available this week, for the July 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGIO... 
Tags Stocks
From Market News Video
Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress
From GlobeNewswire News Releases
Agios Announces Updated Data from ACTIVATE and ACTIVATE-T Phase 3 Studies of Mitapivat in Pyruvate Kinase (PK) Deficiency at the European Hematology Association Virtual Congress
From GlobeNewswire News Releases
Benzinga's Top Ratings Upgrades, Downgrades For June 10, 2021
Upgrades According to Argus Research, the prior rating for Zoom Video Communications Inc (NASDAQ:ZM) was changed from ... 
Tags DQ CLOV CPE
From Benzinga
The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ORMP NVO BNTX
From Benzinga
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ATOS SGTX PRTK
From Benzinga
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VSTM CYCN MSON
From Benzinga
IBD Rating Upgrades: Agios Pharmaceuticals Shows Improved Technical Strength
A Relative Strength Rating upgrade for Agios Pharmaceuticals shows improving technical performance. Will it continue? 
From Investor's Business Daily
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical ... 
Tags GBT PDSB KDNY
From Benzinga
Agios to Present Updated Data from Clinical Trials of Mitapivat in Pyruvate Kinase Deficiency and Thalassemia in Oral Presentations at the European Hematology Association Annual Congress
From GlobeNewswire News Releases
Agios Pharmaceuticals Inc (AGIO) Q1 2021 Earnings Call Transcript
AGIO earnings call for the period ending March 31, 2021. 
Tags Market News AGIO
From Motley Fool
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Guidance RMD AKBA
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.